GNPX
Price
$3.00
Change
+$0.13 (+4.53%)
Updated
Jan 15, 11:34 AM (EDT)
Capitalization
6.54M
Intraday BUY SELL Signals
TLX
Price
$7.46
Change
-$0.16 (-2.10%)
Updated
Jan 15, 12:10 PM (EDT)
Capitalization
2.48B
5 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GNPX vs TLX

Header iconGNPX vs TLX Comparison
Open Charts GNPX vs TLXBanner chart's image
Genprex
Price$3.00
Change+$0.13 (+4.53%)
Volume$5.65K
Capitalization6.54M
Telix Pharmaceuticals
Price$7.46
Change-$0.16 (-2.10%)
Volume$400
Capitalization2.48B
GNPX vs TLX Comparison Chart in %
GNPX
Daily Signal:
Gain/Loss:
TLX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GNPX vs. TLX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a Hold and TLX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (GNPX: $2.87 vs. TLX: $7.62)
Brand notoriety: GNPX and TLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNPX: 509% vs. TLX: 185%
Market capitalization -- GNPX: $6.54M vs. TLX: $2.48B
GNPX [@Biotechnology] is valued at $6.54M. TLX’s [@Biotechnology] market capitalization is $2.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNPX’s FA Score shows that 0 FA rating(s) are green whileTLX’s FA Score has 1 green FA rating(s).

  • GNPX’s FA Score: 0 green, 5 red.
  • TLX’s FA Score: 1 green, 4 red.
According to our system of comparison, both GNPX and TLX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNPX’s TA Score shows that 3 TA indicator(s) are bullish while TLX’s TA Score has 5 bullish TA indicator(s).

  • GNPX’s TA Score: 3 bullish, 4 bearish.
  • TLX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TLX is a better buy in the short-term than GNPX.

Price Growth

GNPX (@Biotechnology) experienced а +51.85% price change this week, while TLX (@Biotechnology) price change was +1.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

TLX is expected to report earnings on Jan 20, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLX($2.48B) has a higher market cap than GNPX($6.54M). TLX has higher P/E ratio than GNPX: TLX (326.39) vs GNPX (0.09). GNPX YTD gains are higher at: 64.000 vs. TLX (1.736). TLX has higher annual earnings (EBITDA): 41.7M vs. GNPX (-16.38M). TLX has more cash in the bank: 207M vs. GNPX (1.1M). GNPX has less debt than TLX: GNPX (279K) vs TLX (418M). TLX has higher revenues than GNPX: TLX (638M) vs GNPX (0).
GNPXTLXGNPX / TLX
Capitalization6.54M2.48B0%
EBITDA-16.38M41.7M-39%
Gain YTD64.0001.7363,687%
P/E Ratio0.09326.390%
Revenue0638M-
Total Cash1.1M207M1%
Total Debt279K418M0%
FUNDAMENTALS RATINGS
GNPX: Fundamental Ratings
GNPX
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNPXTLX
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 8 days ago
70%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
55%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
GNPX
Daily Signal:
Gain/Loss:
TLX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NDVUX17.790.13
+0.74%
MFS New Discovery Value R4
WBVRX31.250.17
+0.55%
William Blair Small Cap Value R6
GAGAX36.510.19
+0.52%
Gabelli Global Rising Income and Div A
MRSHX26.510.02
+0.08%
MFS Research International R3
QCBGX21.83-0.04
-0.18%
Federated Hermes MDT Balanced C

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with NERV. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then NERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
+19.58%
NERV - GNPX
64%
Loosely correlated
+0.94%
TOVX - GNPX
49%
Loosely correlated
-4.88%
OMER - GNPX
48%
Loosely correlated
+3.65%
REVB - GNPX
48%
Loosely correlated
-0.57%
RXRX - GNPX
31%
Poorly correlated
+3.41%
More

TLX and

Correlation & Price change

A.I.dvisor tells us that TLX and GLPG have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLX and GLPG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLX
1D Price
Change %
TLX100%
+2.28%
GLPG - TLX
28%
Poorly correlated
+2.62%
RXRX - TLX
24%
Poorly correlated
+3.41%
GNPX - TLX
24%
Poorly correlated
+19.58%
SNTI - TLX
24%
Poorly correlated
+3.77%
RGNX - TLX
23%
Poorly correlated
-0.66%
More